These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4641003)

  • 21. The loci of -bungarotoxin action on the muscle postjunctional membrane.
    Magazanik LG; Vyskocil F
    Brain Res; 1972 Dec; 48():420-3. PubMed ID: 4539493
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of frog sartorius muscle acetylcholine receptor using the irreversible inhibitor TDF.
    Lindstrom JM; Singer SJ; Lennox ES
    J Membr Biol; 1972; 9(2):155-76. PubMed ID: 5084458
    [No Abstract]   [Full Text] [Related]  

  • 23. The desensitization of postjunctional muscle membrane after intracellular application of membrane stabilizers and snake venom polypeptides.
    Vyskocil F; Magazanik LG
    Brain Res; 1972 Dec; 48():417-9. PubMed ID: 4539492
    [No Abstract]   [Full Text] [Related]  

  • 24. Acetylcholine: possible neuromuscular transmitter in Crustacea.
    Futamachi KJ
    Science; 1972 Mar; 175(4028):1373-5. PubMed ID: 4333882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The statistical nature of the acetycholine potential and its molecular components.
    Katz B; Miledi R
    J Physiol; 1972 Aug; 224(3):665-99. PubMed ID: 5071933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the electrophoretic application of sulfhydryl reagents to the end-plate receptors.
    Del Castillo J; Escobar I; Gijón E
    Int J Neurosci; 1971 Feb; 1(3):199-209. PubMed ID: 4349430
    [No Abstract]   [Full Text] [Related]  

  • 27. Competitive block and ion channel block as mechanisms of antagonist action on the skeletal muscle end-plate.
    Colquhoun D
    Adv Biochem Psychopharmacol; 1980; 21():67-80. PubMed ID: 6246760
    [No Abstract]   [Full Text] [Related]  

  • 28. Differences between the effects of saxitoxin (paralytic shellfish poison) and tetrodotoxin on the frog neuromuscular junction.
    Evans MH
    Br J Pharmacol; 1969 Jul; 36(3):426-36. PubMed ID: 5789803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of -bungarotoxin to acetylcholine receptors in mammalian muscle (snake venom-denervated muscle-neonatal muscle-rat diaphragm-SDS-polyacrylamide gel electrophoresis).
    Berg DK; Kelly RB; Sargent PB; Williamson P; Hall ZW
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):147-51. PubMed ID: 4333037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative neuromuscular action of Naja nigricollis venom and the neurotoxin (alpha-najatoxin) which is extracted from it].
    Cheymol J; Bourillet F; Roch-Arveiller M
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):26-36. PubMed ID: 5093189
    [No Abstract]   [Full Text] [Related]  

  • 31. Reversibility of neuromuscular blockade by neurotoxins from elapid and sea snake venoms.
    Lee CY; Chang CC; Chen YM
    Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):344-9. PubMed ID: 4267234
    [No Abstract]   [Full Text] [Related]  

  • 32. Action of anatoxin I at the neuromuscular junction.
    Biggs DF; Dryden WF
    Proc West Pharmacol Soc; 1977; 20():461-6. PubMed ID: 408823
    [No Abstract]   [Full Text] [Related]  

  • 33. Membrane surface potential changes may alter drug interactions: an example, acetylcholine and curare.
    Van der Kloot WG; Cohen I
    Science; 1979 Mar; 203(4387):1351-2. PubMed ID: 424757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of carbachol and alpha-bungarotoxin on the frequency of miniature endplate potentials at the frog neuromuscular junction.
    Bukharaeva E; Ipatova T; Nikolsky EE; Vyskocil F
    Exp Physiol; 2000 Mar; 85(2):125-31. PubMed ID: 10751508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are the blockade of nerve conduction and depolarization of skeletal muscle induced by cobra venom due to phospholipase A, neurotoxin or cardiotoxin?
    Chang CC; Wei JW; Chuang ST; Lee CY
    Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):323-7. PubMed ID: 4512907
    [No Abstract]   [Full Text] [Related]  

  • 36. Response augmentation and blockade in cholinergic neuromuscular tissues.
    Friess SL
    Neurosci Res (N Y); 1969; 2(0):203-28. PubMed ID: 4152426
    [No Abstract]   [Full Text] [Related]  

  • 37. Voltage-dependence of drug-induced conductance in frog neuromuscular junction.
    Neher E; Sakmann B
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2140-4. PubMed ID: 1079601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of pharmacological approaches to the acetylcholine receptors at the neuromuscular junction.
    Waud DR
    Ann N Y Acad Sci; 1971 Sep; 183():147-57. PubMed ID: 4330758
    [No Abstract]   [Full Text] [Related]  

  • 39. Tubocurarine, a partial agonist for cholinergic receptors.
    Trautmann A
    J Neural Transm Suppl; 1983; 18():353-61. PubMed ID: 6308151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of scorpion toxin II in the skeletal muscle.
    Lin SS; Tseng WC; Lee CY
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(4):359-68. PubMed ID: 1161059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.